Skip to main content

Burgess Ernest G III's Form 4 filing

National Healthcare Corp (NHC) · filed Dec 7, 2022

Accession no.
0001437749-22-028675
Filed
Dec 7, 2022
Trade date
Nov 30-Dec 6, 2022
Filing delay
7 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $819.5K. It was filed 7 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Burgess Ernest G IIICIK 0001012856Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 30, 2022Shares of Common StockSSaleDisposed−1,142$60.71−$69,330.8293,002Direct
Nov 30, 2022Shares of Common StockSSaleDisposed−1,302$61.13−$79,591.2691,700Direct
Dec 1, 2022Shares of Common StockSSaleDisposed−388$60.37−$23,423.5691,312Direct
Dec 1, 2022Shares of Common StockSSaleDisposed−500$61.00−$30,50090,812Direct
Dec 2, 2022Shares of Common StockSSaleDisposed−4,261$61.23−$260,901.0386,551Direct
Dec 2, 2022Shares of Common StockSSaleDisposed−3,391$60.89−$206,477.9983,160Direct
Dec 5, 2022Shares of Common StockSSaleDisposed−1,929$61.15−$117,958.3581,231Direct
Dec 6, 2022Shares of Common StockSSaleDisposed−531$58.90−$31,275.980,700Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)